Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W J Poo

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Biochemical Pharmacology|March 7, 1997
Immunomodulation and enhancement of antitumor activity by co-administration of 1,3-bis(2-chloroethyl)-1-nitrosourea and thymidineW J Poo, X Guo, B Haslund, et al.
The Journal of Urology|July 1, 1995
Prognostic factors for survival in patients with metastatic renal cancer treated with biological response modifiersS Mani, M B Todd, K Katz, et al.
Plastic and Reconstructive Surgery|November 1, 1995
Multiple primary melanomas: data and significanceS Ariyan, W J Poo, J Bolognia, et al.
Annals of Plastic Surgery|September 1, 1996
Prolonged survival in patients with advanced melanoma treated with neoadjuvant chemotherapy followed by resectionH N Sasson, W J Poo, M H Bakas, et al.
Connecticut Medicine|August 26, 1999
The predictive value of lymphoscintigraphy for nodal metastases of cutaneous melanomaP L Stephens, S Ariyan, R V Ocampo, et al.
Journal of Interferon Research|August 1, 1986
The effect of hydrocortisone on the production of gamma-interferon and other lymphokines by human peripheral blood mononuclear cellsT C Cesario, L Slater, W J Poo, et al.
American Journal of Clinical Oncology|October 1, 1994
Neuron-specific enolase as a tumor marker in metastatic melanomaA C Buzaid, A B Sandler, C L Hayden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Role of computed tomography in the staging of primary melanomaA C Buzaid, A B Sandler, S Mani, et al.
The International Journal of Biological Markers|October 1, 1994
Correlation between lipid-associated sialic acid and tumor burden in melanomaA C Buzaid, A B Sandler, C L Hayden, et al.
Cancer|December 11, 1999
Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanomaW J Poo-Hwu, S Ariyan, L Lamb, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Biochemical Pharmacology|March 7, 1997
Immunomodulation and enhancement of antitumor activity by co-administration of 1,3-bis(2-chloroethyl)-1-nitrosourea and thymidineW J Poo, X Guo, B Haslund, et al.
The Journal of Urology|July 1, 1995
Prognostic factors for survival in patients with metastatic renal cancer treated with biological response modifiersS Mani, M B Todd, K Katz, et al.
Plastic and Reconstructive Surgery|November 1, 1995
Multiple primary melanomas: data and significanceS Ariyan, W J Poo, J Bolognia, et al.
Annals of Plastic Surgery|September 1, 1996
Prolonged survival in patients with advanced melanoma treated with neoadjuvant chemotherapy followed by resectionH N Sasson, W J Poo, M H Bakas, et al.
Connecticut Medicine|August 26, 1999
The predictive value of lymphoscintigraphy for nodal metastases of cutaneous melanomaP L Stephens, S Ariyan, R V Ocampo, et al.
Journal of Interferon Research|August 1, 1986
The effect of hydrocortisone on the production of gamma-interferon and other lymphokines by human peripheral blood mononuclear cellsT C Cesario, L Slater, W J Poo, et al.
American Journal of Clinical Oncology|October 1, 1994
Neuron-specific enolase as a tumor marker in metastatic melanomaA C Buzaid, A B Sandler, C L Hayden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Role of computed tomography in the staging of primary melanomaA C Buzaid, A B Sandler, S Mani, et al.
The International Journal of Biological Markers|October 1, 1994
Correlation between lipid-associated sialic acid and tumor burden in melanomaA C Buzaid, A B Sandler, C L Hayden, et al.
Cancer|December 11, 1999
Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanomaW J Poo-Hwu, S Ariyan, L Lamb, et al.
Pageof 3